Nr 546 week 5 Study guides, Class notes & Summaries

NR 546 Week 7 Case Study: Child and Adolescent (Solved). Subjective Objective The client is a 7-year-old male accompanied by his mother and 9-year-old brother. Client’s Chief Complaints: “My son has endless energy, he can’t sit still. When he plays, he is too rough with other kids.” History of Present Illness This clint was previously diagnosed with attentiondeficit/hyperactivity disorder (ADHD). The school reports that he cannot stay seated, frequently calls out in class, is d...

NR 546 Week 5 Case study Questions and Answers (2024 / 2025) (Verified Answers) NR 546 Week 5 Case study Questions and Answers (2024 / 2025) (Verified Answers) NR 546 Week 5 Case study Questions and Answers (2024 / 2025) (Verified Answers) NR 546 Week 5 Case study Questions and Answers (2024 / 2025) (Verified Answers) NR 546 Week 5 Case study Questions and Answers (2024 / 2025) (Verified Answers) NR 546 Week 5 Case study Questions and Answers (2024 / 2025) (Verified Answers)

Study guide NR 546 Week 5 Case study

NR 546 Week 3 Discussion Schizophrenia Chamberlain NR 546 Week 3 Discussion: Schizophrenia 1. Selectone drugtotreatthe diagnosis(es)orsymptoms. 2. Listmedicationclassandmechanismofactionforthechosenmedication. 3. Writetheprescriptioninprescriptionformat. 4. Provide an evidence-based rationale for the selected medication 5. List any side effects or adverse effects associated with the medication. 6. Include any required diagnostic testing. State the time frame for this testing...

NR 546 WEEK 7 ADHD Medication Table. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediateacting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulatio...

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table-2023

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table-2023

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2024 GRADED A+

NR 546 Week 3 Discussion: Schizophrenia 1. Selectone drugtotreatthe diagnosis(es)orsymptoms. 2. Listmedicationclassandmechanismofactionforthechosenmedication. 3. Writetheprescriptioninprescriptionformat. 4. Provide an evidence-based rationale for the selected medication 5. List any side effects or adverse effects associated with the medication. 6. Include any required diagnostic testing. State the time frame for this testing (testing is before medication initiation or q 3 month...

Study guide NR 546 Week 5 Case study